GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » 1-Year ROIIC %

Orchid Pharma (NSE:ORCHPHARMA) 1-Year ROIIC % : -25.44% (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Orchid Pharma's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was -25.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Orchid Pharma's 1-Year ROIIC % or its related term are showing as below:

NSE:ORCHPHARMA's 1-Year ROIIC % is ranked worse than
69.11% of 1010 companies
in the Drug Manufacturers industry
Industry Median: 1.6 vs NSE:ORCHPHARMA: -25.44

Orchid Pharma 1-Year ROIIC % Historical Data

The historical data trend for Orchid Pharma's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma 1-Year ROIIC % Chart

Orchid Pharma Annual Data
Trend Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 -11.70 26.41 73.47 11.89

Orchid Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.01 - 11.89 - -25.44

Competitive Comparison of Orchid Pharma's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Orchid Pharma's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orchid Pharma's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orchid Pharma's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Orchid Pharma's 1-Year ROIIC % falls into.



Orchid Pharma 1-Year ROIIC % Calculation

Orchid Pharma's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 173.6917 (Sep. 2024) - 51.628 (Sep. 2023) )/( 11633.768 (Sep. 2024) - 12113.592 (Sep. 2023) )
=122.0637/-479.824
=-25.44%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Orchid Pharma  (NSE:ORCHPHARMA) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Orchid Pharma 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orchid Pharma Business Description

Traded in Other Exchanges
Address
Sector 74A, 15th Floor, Tower-1, DLF Corporate Greens, Narsinghpur, Gurugram, HR, IND, 122004
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Cephalosporin Pharmaceuticals, in which the Company drives its major sales through Active Pharmaceuticals Ingredients. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma Headlines

No Headlines